Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical Support.
Where this comes from
- Record sourced from PubMed, PMID 32223599.
- Also identified by DOI 10.18553/jmcp.2020.26.4.400 and PMC identifier 10391119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study received unrestricted funding from the Pharmaceutical Research Manufacturers of America. The authors also do consulting, personally or through their employment, with numerous pharmaceutical manufacturers, payers, and other stakeholders with a general interest in this subject matter.
Medical subject headings
- Cost-Benefit Analysis
- Insurance, Pharmaceutical Services
- Pharmacy Research
- Uncertainty
- Value-Based Health Insurance